3rd Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery
High Throughput Technology for Hit Generation
Virtual Event May 31-June 1, 2023
Confirmed speakers
Improved ASMS Affinity Ranking Using Complete Analysis of Target Titration Data
Dr Brett BABIN
GENENTECH, South San Francicsco, United States
MALDI MS-based Cell Assays in Pharmaceutical R&D – a Perspective
Prof. Carsten HOPF
UNIVERSITY OF MANNHEIM, Mannheim, Germany
Deploying Affinity Selection Mass Spectrometry (ASMS) for Rapid and Flexible Hit Confirmation of DNA-Encoded Library (DEL) Screening in Targeted Protein Modulation (TPM)
Dr Daniel MEDINA-CLEGHORN
NURIX THERAPEUTICS, San Francisco, United States
Affinity Selection Mass Spectrometry: Hit Validation Tool and a Promising High Throughput Screening Platform for Drug Targets
Dr Omprakash NACHAM
ABBVIE, North Chicago, United States
Setting up an AS-MS Screening Method in Pharmaceutical Industry
Mr Kai SINERVO
ORION CORPORATION, Espoo, Finland
Continued Development of Acoustic Mist Ionization Mass Spectrometry and Future High Throughput MS Technologies